Page 49 - ESHRE2019

Conclusions (2)
4. It is not possible to test everyone due to technical limitations of SDF assays.
5. It seems sound to test, in particular, the patients in whom interventions can be offered to reduce SDF and/or improve ART outcomes.
6. Cost-effectiveness of SDF testing based on clinical scenarios vs. routine testing to be determined.
Esteves, 45
THANK YOU
Dr. Sandro Esteves
Dr. Marcelo Scandiucci Dr. José Eduardo Orosz Dr. Renan Andreollo Fabiola Bento
Cristiane Medina Sidney Verza Jr. Camila Pompeu Vanessa Moreno
Ellen Silva
Roseane Oliveira
Thais Paiva
Katia Pereira
Sandra Souza
Leila Simplicio
Shirley Machado Jonathan Santos
Dr. Silval Zabaglia Dra. Fabiana Nakano Dr. Julio Voget
Dr. Ricardo Miyaoka Dr. Ricardo Barini
Dr. Wail Margeotto Dra. Cristiane Moreira Dr. Arnaldo Gomes Marisa Russo
Ivanete Santos Sandra Santana
Ana Paula Barbosa Ana Pastorelli
43
PRECONGRESS COURSE 01 I VIENNA, AUSTRIA – 23 JUNE 2019 47